0.1% topical sirolimus in the treatment of cutaneous microcystic lymphatic malformations in children and adults: phase II, split-body randomized, double-blind, vehicle-controlled clinical trial 0.1% topical sirolimus in the treatment of cutaneous microcystic lymphatic malformations in children ...
0.1% topical sirolimus in the treatment of cutaneous microcystic lymphatic malformations in children and adults: phase II, split-body randomized, double-blind, vehicle-controlled clinical trial - TOPICAL 0.1% topical sirolimus in the treatment of cutaneous microcystic lymphatic malformations in children ...
Cutaneous microcystic lymphatic malformations (CMLM) in children and adults MedDRA version: 20.0;Level: LLT;Classification code 10003229;Term: Arteriovenous malformations;System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15] Cutaneous microcystic lymphatic malformations (CMLM) in children and adults MedDRA version: 20.0;Lev ...